Michelle Doig

Michelle Doig

50 year
Finance
Health Technology
Consumer Services

Profile

Michelle joined Omega Funds in 2016.
She has over 20 years of experience advising life sciences companies on private placements, public equity financing and M&A transactions.
Michelle currently serves on the Board of Directors of Artios Pharma and is a board observer at Arrakis Therapeutics.
Previously, Michelle was Director of Corporate Finance at Third Rock Ventures, where she supported numerous portfolio companies through their initial private and public financings.
Prior to joining Third Rock, Michelle was a Principal at Abingworth in London and Boston.
She was also a life sciences investment banker with Lehman Brothers International in London, JP Morgan/H&Q in New York and Morgan Stanley in Toronto and New York.
Michelle has executed more than 50 equity and convertible transactions and numerous IPOs, private placements and M&A transactions for companies, including Gilead, MedImmune, Millennium, Illumina and Sepracor.
Michelle graduated with an Honor’s degree in Business Administration from the Richard Ivey School of Business at the University of Western Ontario in London.

Michelle Doig active positions

CompaniesPositionStart
OMEGA ALPHA SPAC Founder 2020-10-31
Private Equity Investor 2016-11-30
Director/Board Member -
Director/Board Member 2021-06-30
All active positions of Michelle Doig

Former positions of Michelle Doig

CompaniesPositionEnd
NUVATION BIO INC. Director/Board Member 2021-07-30
Private Equity Investor 2016-12-30
Corporate Officer/Principal 2013-10-31
Corporate Officer/Principal 2001-12-31
Corporate Officer/Principal 2001-02-28
See the detail of Michelle Doig's experience

Training of Michelle Doig

Richard Ivey School of Business Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michelle Doig's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MORGAN STANLEY

Finance

NUVATION BIO INC.

Health Technology

Private companies8

Finance

Finance

Finance

Health Technology

Finance

Health Technology

Finance

Finance

See company connections
  1. Stock
  2. Insiders
  3. Michelle Doig
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer